ICL Group Ltd (ICL)

TEL AVIV, Israel , Aug. 13, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2025.

ICL Group Ltd (NYSE:ICL ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants Aviram Lahav - Chief Financial Officer Elad Aharonson - President & CEO Peggy Reilly Tharp - Vice President of Global Investor Relations Conference Call Participants Benjamin M. Theurer - Barclays Bank PLC, Research Division Joel Jackson - BMO Capital Markets Equity Research Kevin Estok - Jefferies LLC, Research Division Operator Good morning, ladies and gentlemen, and welcome to the ICL Second Quarter 2025 Earnings Conference Call.

ICL Group (ICL) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.1 per share a year ago.

TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2025. Consolidated sales were $1.8 billion, up ~$80 million versus the prior year. Operating income was $181 million versus $211 million of operating income in the second quarter of last year, with adjusted operating income of $201 million versus $225 million. For the second quarter, net income attribu.

TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release second quarter 2025 results prior to the opening of the TASE market on Wednesday, August 6, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv).

REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd.  (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to drive innovation in life-science product development, today announced the successful completion and closing of the previously disclosed transaction involving the divestiture of the majority of the activities and assets of its ag-biologicals subsidiary, Lavie Bio Ltd.

TEL AVIV, Israel , May 21, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its first quarter results for the period ending March 31, 2025.

ICL sees higher sales across its Industrial Products, Phosphate Solutions and Growing Solutions units in Q1.

ICL Group (ICL) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.09 per share a year ago.

ICL Group Ltd (NYSE:ICL ) Q1 2025 Earnings Conference Call May 19, 2025 4:00 AM ET Company Participants Peggy Reilly Tharp - Vice President, Global Investor Relations Elad Aharonson - President and Chief Executive Officer Aviram Lahav - Chief Financial Officer Conference Call Participants Rahi Parikh - Barclays Bank Operator Good morning, ladies and gentlemen, and welcome to the ICL First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode.

TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Consolidated sales were $1.8 billion versus $1.7 billion in the prior year. Operating income was $185 million versus $203 million of operating income in the first quarter of last year, with adjusted operating income of $208 million versus $215 million. For the first quarter, net income attributab.

ICL Group (ICL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening of the TASE market on Monday, May 19, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv). The.

ICL Group (ICL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Lavie Bio improves agriculture productivity and sustainability through microbiome-based ag-biological products REHOVOT, Israel , April 21, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product discovery and development, today announced the signing of a definitive agreement under which ICL, will acquire the majority of activity of Evogene's subsidiary, Lavie Bio Ltd.

TEL AVIV, Israel , March 27, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its fourth quarter and annual results for the period ending December 31, 2024.